KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
KLRS
84 hedge funds and large institutions have $329M invested in Kalaris Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 28 reducing their positions, and 13 closing their positions.
Holders
84
Holders Change
+4
Holders Change %
+5%
% of All Funds
1.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
25
Reduced
28
Closed
13
Calls
$647K
Puts
$321K
Net Calls
+$326K
Net Calls Change
-$1M
Top Buyers
1 |
1
BlackRock
New York
|
$28.1M |
2 |
![]()
2
Marshall Wace
London,
United Kingdom
|
$4.24M |
3 |
GC
3
GMT Capital
Atlanta,
Georgia
|
$8.69M |
4 |
GCP
4
GSA Capital Partners
London,
United Kingdom
|
$1.42M |
5 |
5
Bank of America
Charlotte,
North Carolina
|
$1.43M |